로딩 중…
지수 로딩 중…
Aquestive Therapeutics, Inc.
AQST· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.79+2.43%
2026-08-03
Financials
Valuation Metrics
Aquestive Therapeutics, Inc.'s Market Cap is $475M. At end of 2025 it was $788M. Ranked #2825 of 3,112 in US market (top 91%), #1238 of 1,445 on NASDAQ (top 86%), #228 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 85%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $475M | US#2,825/3,112 Sec#228/269 |
| Revenue | $50M | US#2,862/3,112 Sec#156/269 |
| Net Income | $-69M | US—/3,112 Sec—/269 |
| Total Assets | $141M | US#3,011/3,112 Sec#256/269 |
| Net Assets | $-34M | US#3,011/3,112 Sec#263/269 |
| Value | ||
| P/S | 9.46x | US#2,634/3,112 Sec#116/269 |
| FCF Yield | -9.32% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROA | -48.83% | US#2,962/3,112 Sec#214/269 |
| Op. Margin | -111.18% | US#2,829/3,112 Sec#126/269 |
| Revenue Growth | 65.67% | US#226/3,112 Sec#46/269 |
| Financial Health | ||
| Total Debt | $134M | US#2,314/3,112 Sec#108/269 |
| FCF | $-44M | US#2,457/3,112 Sec#112/269 |
| Cash | $111M | US#2,164/3,112 Sec#173/269 |
| Current Ratio | 4.10x | US#583/3,112 Sec#166/269 |
| Performance | ||
| 1Y Return | -0.79% | US#2,241/3,112 Sec#205/269 |
| 1M Return | -9.33% | US#2,558/3,112 Sec#160/269 |
| From 52W High | -49.80% | US#2,780/3,112 Sec#219/269 |
| 1Y MDD | -60.61% | US#2,738/3,112 Sec#214/269 |
| Trading | ||
| Volume | 2,368,848 shares | US#771/3,112 Sec#69/269 |
| Trading Value | $9M | US#2,393/3,112 Sec#189/269 |
| Per Share | ||
| EPS | $-0.69 | US—/3,112 Sec—/269 |